UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 24, 2023
Accession Number:
0001193125-23-280687
Submission Type:
POS AM
CIK:
0001069308
Company Name:
Acer Therapeutics Inc.
File Number:
333-261342